• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 564-578 of 1,037 results

1201 Exhibit: SUPPLEMENTAL DECLARATION OF MAUREEN DONOVAN, PhD

Document IPR2019-00688, No. 1201-301 Exhibit - SUPPLEMENTAL DECLARATION OF MAUREEN DONOVAN, PhD (P.T.A.B. Mar. 12, 2020)

cite Cite Document

1237 Exhibit: Nalox1237 Talton 2000

Document IPR2019-00688, No. 1237-287 Exhibit - Nalox1237 Talton 2000 (P.T.A.B. Mar. 12, 2020)

cite Cite Document

1215 Exhibit: Nalox1215 Hochhaus 1995

Document IPR2019-00688, No. 1215-266 Exhibit - Nalox1215 Hochhaus 1995 (P.T.A.B. Mar. 12, 2020)

cite Cite Document

2127 Exhibit: Ex 2127 Emergent Adapt Acquisition

Document IPR2019-00688, No. 2127-164 Exhibit - Ex 2127 Emergent Adapt Acquisition (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2076 Exhibit: Ex 2076 EMA Guideline on Excipients

Document IPR2019-00688, No. 2076-132 Exhibit - Ex 2076 EMA Guideline on Excipients (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2170 Exhibit: Ex 2170 Mogelefsky

Document IPR2019-00688, No. 2170-206 Exhibit - Ex 2170 Mogelefsky (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2197 Exhibit: Ex 2197 Bloomberg Symphony FAQs

Document IPR2019-00688, No. 2197-229 Exhibit - Ex 2197 Bloomberg Symphony FAQs (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2150 Exhibit: Ex 2150 NACo Press Release

Document IPR2019-00688, No. 2150-186 Exhibit - Ex 2150 NACo Press Release (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2120 Exhibit: Ex 2120 NarcanR Nasal Spray Consumer FAQs

Document IPR2019-00688, No. 2120-157 Exhibit - Ex 2120 NarcanR Nasal Spray Consumer FAQs (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2121 Exhibit: Ex 2121 How to Get NarcanR Nasal Spray

Document IPR2019-00688, No. 2121-158 Exhibit - Ex 2121 How to Get NarcanR Nasal Spray (P.T.A.B. Dec. 20, 2019)

cite Cite Document

2046 Exhibit: Ex 2046 EvzioR Label

Document IPR2019-00688, No. 2046-108 Exhibit - Ex 2046 EvzioR Label (P.T.A.B. Dec. 19, 2019)

cite Cite Document

2045 Exhibit: Ex 2045 Hospira Naloxone HCl Label

Document IPR2019-00688, No. 2045-107 Exhibit - Ex 2045 Hospira Naloxone HCl Label (P.T.A.B. Dec. 19, 2019)

cite Cite Document

2054 Exhibit: Ex 2054 AHFS

Document IPR2019-00688, No. 2054-116 Exhibit - Ex 2054 AHFS (P.T.A.B. Dec. 19, 2019)

cite Cite Document

2025 Exhibit: Opiant2025 Teva Case Claim Construction Opinion

Document IPR2019-00688, No. 2025-91 Exhibit - Opiant2025 Teva Case Claim Construction Opinion (P.T.A.B. Jun. 10, 2019)

cite Cite Document

2204 Exhibit: Ex 2204 Karas IPR Declaration 688

Document IPR2019-00688, No. 2204-252 Exhibit - Ex 2204 Karas IPR Declaration 688 (P.T.A.B. Dec. 23, 2019)

cite Cite Document
<< 1 2 3 4 5 ... 38 39 40 41 42 ... >>